Departmental Seminar – Friday October 9

October 4th, 2015 in Spotlight

October 9 – Friday @ 2:00

“Dynamin, a Novel PharmacologicalTarget in Chronic Kidney Disease”

Sanja Sever, PhD

Assistant Professor of Medicine, Nephrology Division
Massachusetts General Hospital; Harvard Medical School

Refreshments at 1:45 p.m.

670 Albany Street – Lobby Level #107/108


Program Director, Barbara Slack, PhD
Program Coordinator: Debra Kiley, 414-7914

Target Audience: Faculty, Students, Residents, Greater Boston Scientific Community (advertised in MIT’s Bulletin).

At the conclusion of this activity participants will be able to: 1) recognize the latest insights into the molecular mechanisms that underlie chronic kidney diseases (CKDs), such as dis-regulation of the actin cytoskeleton in podocytes as well as the role of regulatory GTPase dynamin in regulating actin cytoskeleton; 2) recall that dysregulation of the actin cytoskeleton in podocytes represents a common pathway in the pathogenesis of proteinuria across a spectrum of chronic kidney diseases (CKD) and 3) state that chronic kidney disease (CKD) affects hundreds of millions of peo­ple worldwide.

September 2015

October 4th, 2015 in Uncategorized


  • Parul Agnihotri, PhD Candidate in Susan Winandy’s Lab was elected Vice President of the Boston University Graduate Medical Sciences Student Organization (GMSSO) for 2015-2016 effective this month. The GMSSO is a student run organization that works to unite students from all departments and schools on the Medical Campus, to share ideas and address questions or concerns pertaining to student life. Through organizing various social and community service activities, GMSSO is an outlet for students to get involved in the BU Graduate Medical Sciences community, both on and off campus.
  • For six weeks, Jason Sutin, Pathology PhD Candidate in Maria Franceschini’s Lab at MGH will be working with the CURE Children’s Hospital of Uganda in Mbale, Uganda, Africa on a collaboration to study the effect of surgical treatment of infant hydrocephalus on cerebral blood flow and oxygen metabolism.
  • Nader Rahimi and his Lab’s recent publication on the characterization of a novel adhesion molecule (TMIGD1) was on the news:
  • Several Department of Pathology members participated in the 2015 Boston Heart Walk on Saturday, September 12th sponsored by the American Heart Association. BRAVO!!! The AHA MISSION: Building healthier lives, free of cardiovascular diseases and stroke. Their IMPACT: By 2020, to improve the cardiovascular health of all Americans by 20 percent while reducing deaths from cardiovascular disease and stroke by 20 percent. In 1999, the American Heart Association set a bold 10-year goal: To reduce coronary heart disease, stroke and risk by 25 percent by 2010. We achieved the reduction in deaths ahead of schedule and made substantial progress against three of the six risk factors. Our 2020 Impact Goal focuses on helping people build stronger health and a better quality of life.
  • Dequina Nicholas, PhD from Loma Linda Medical School, (2015) has joined the labs of Barbara Nikolajczyk and Gerald Denis as an Inflammation Training Grant-supported post-doctoral full. Welcome Dequina!
  • On September 15th the department held a Faculty Meeting that included faculty, residents, postdocs and graduate students devoted to addressing professionalism in the workplace. The meeting will also include professionalism vignettes that were presented at the Association of Pathology Chairs meeting this summer. GroupPhoto2

           Dr. David Kindelberger introduced several vignettes on Professionalism:


           Dr. O’Brien spoke on Altruism:


           Dr. Chris Andry addressed Accountability:

Dr. Andry

          Dr. Karen Quillen talked about Respect:

Dr. Quillen

Additional comments by Dr. Barbara Slack:


And Dr. Carl O’Hara:

Dr. O.Hara

Rally for Research September 16 & 17 2015

The rally for research #rallymedres was held in Washington DC to advocate for increased funding for the National Institutes of Health (NIH). Advocates from 40 states and more than 200 organizations spoke with their Senators and Congressman about the need for robust, predictable and sustainable NIH funding. The key messages that were delivered included the fact that since 2004 there has been a 24% decrease in the dollars available for NIH investigators (adjusted for inflation). In prior years there was a 1 in 3 chance that a grant would be funded, with the current paylines there is a 1 in 7 chance.

The Association of Pathology Chairs was represented at the rally by Daniel Remick, M.D., Chair of Pathology and Laboratory Medicine at Boston University School of Medicine #DanielRemick1 who provided twitter updates throughout the rally.

After orientation on September 16th the 300 rally participants were bused to the Capital for a rally held in the Kennedy Caucus room. Presentations were made by Jerry Moran (R-Kansas), Senator Durbin (D-Illinois), Patti Murray (D-Washington) and Amy Klobuchar (D-Minnesota). Each of these Senators expressed strong bipartisan support to increase NIH funding. Senator Murray talked about the need for NIH funding to maintain American exceptionalism. Senator Klobuchar is such a strong NIH supporter that during the last government shutdown, she donated her salary to the NIH. Francis Collins, the Director of NIH spoke passionately about funding saying we cannot wait for cure and we cannot wait for hope. Patient advocates also spoke about why NIH funding saves lives.

The next morning, September 17th 2015, Representative Tom Cole (R-Oklahoma), the fourth ranking Republican in the House of Representatives addressed participants. He emphasized that Congress is eager to show bipartisan legislation that helps the country, and increased funding for NIH was a clear example of this. The rally participants then met with members of Congress and their staff.

The delegation from Massachusetts consisted of Daniel Remick, M.D., Chair and Professor of Pathology & Lab Medicine, Boston University School of Medicine, Susan Hankinson, Sc.D., Chair of Biostatistics and Epidemiology, Health Sciences University of Massachusetts and Timothy Leshan, Northeastern University Vice President Government Relations. The delegation met with our Senators and Representatives. We met with Ashley Coulombe, Special Assistant to Senator Elizabeth Warren first and relayed specific examples of how decreased NIH funding has hurt research. The next meeting was with Andrew Cohen, Counsel to Senator Edward Markey. Senator Markey has long supported funding for NIH.

The delegation was fortunate to spend 30 minutes with Rep. Joseph Kennedy from the 4th district of Massachusetts (see picture). The day finished with meetings with Jennifer Chandler, Senior Legislative Assistant to Rep. James McGovern and a final meeting the Rep. Capuaon’s Chief of Staff Robert Primus.


All the Massachusetts legislators strongly support increased funding for the mission of NIH but the MA delegates were able to provide several reasons why increased NIH funding is a national imperative.


  • Su N, Choi HP, Yang Jing-Hua, Wang F, Su H, Fei Z and Azadzoi KM entitled Quantitative Proteomic Analysis of Differentially Expressed Proteins and Downstream Signaling Pathways in Chronic Bladder Ischemia” has been accepted for publication in the Journal of Urology.

Departmental Seminar – Friday October 2

September 24th, 2015 in Spotlight

October 2 – Friday @ 2:00

“How Presenilin Mutations Cause Alzheimer’s Disease”

Raymond Kelleher III, MD, PhD

Associate Professor of Neurology
Principal Investigator, Center for Human Genetic Research
Massachusetts General Hospital; Harvard Medical School

Refreshments at 1:45 p.m.

670 Albany Street – Lobby Level #107/108


Program Director, Barbara Slack, PhD
Program Coordinator: Debra Kiley, 414-7914

Target Audience: Faculty, Students, Residents, Greater Boston Scientific Community (advertised in MIT’s Bulletin).

At the conclusion of this activity participants will be able to: 1) ) state that mutations in the Presenilin-1 (PSEN1) gene are the major cause of familial Alzheimer’s disease (FAD); 2) report that Presenilins play essential roles in memory formation,     synaptic function, and neuronal survival and 3) recognize that how PSEN1 mutations cause  FAD is unclear, and pathogenic  mechanisms based on gain or loss of function have been proposed.

Inflammation Symposium – Tuesday September 22

September 16th, 2015 in Spotlight

Inflammation Symposium: Bipartisan Support by PAMPS and DAMPS


Tuesday, September 22

3-5 p.m., Hiebert Lounge, BUSM Instructional Building


Medical Campus students, faculty and staff are invited to a two-hour symposium to explore the complex interactions that occur during an inflammatory response.Symposium is hosted by Barbara Nikolajczyk, PhD and Dan Remick, MD.


Inflammation Resulting from Pathogen-Associated Molecular Patterns (PAMPS)

Moderator/Provocateur: Daniel Remick, MD, Chair and Professor of Pathology and Laboratory Medicine


Time Speaker Title of talk
3-3:05 p.m. Barbara Nikolajczyk, PhD Department of Microbiology & Pathology and Lab Medicine Introduction
3:05-3:15 Lee Quinton, PhDDepartment of Medicine Damage Control: Regulating Acute Pulmonary Inflammation during Pneumonia
3:15- 3:25 Alan Walkey, MD, MScDepartment of Medicine PAMPS are prologue, but DAMPS hold the plot: a clinico-epidemiological perspective of sepsis
3:25-3:35 Robin Ingalls, MDDepartments of Medicine and Microbiology Chlamydia, innate immunity, and the role of host tolerance in disease pathogenesis
3:35- 3:45 Deborah Stearns-Kurosawa, PhDDepartment of Pathology and Laboratory Medicine 160 Easy Steps To Avoid Hemolytic Uremic Syndrome from toxigenic E.coli
3:45-4 Panel Exploration of potential new collaborations and questions from the floor



Inflammation Resulting from Danger-Associated Molecular Patterns (DAMPS)

Moderator/Provocateur Lee Wetzler, MD, Professor of Medicine, PI of the Inflammation Training Grant


Time Speaker Title of talk
4-4:10 Maria Trojanowska, PhDDepartment of Medicine Fresh insights into the role of herpesviruses (CMV and EBV) in the pathogenesis of scleroderma
4:10-4:20 Joel Henderson, MD, PhDDepartment of Pathology and Laboratory Medicine Molecular response patterns in hypertension-associated renal glomerular injury
4:20-4:30 Kei Yasuda, PhDDepartment of Medicine Interferon regulatory factor-5 contributes to the disease pathogenesis in systemic lupus erythematosus: what is the mechanism?
4:30-4:40 Valentina Perissi, PhDDepartment of Biochemistry Braking on ubiquitination to prevent aberrant activation of TLR signaling
4:40-5 Panel Exploration of potential new collaborations and questions from the floor



August 2015

September 8th, 2015 in Uncategorized

Pathology & Laboratory Medicine News Items – August 2015



  • Please join me in congratulating Dr. David Kindelberger on his appointment as an Associate Professor of Pathology and Laboratory Medicine. President Brown just approved his appointment. Appointment or promotion to Associate Professor is a significant achievement and acknowledges that Dr. Kindelberger enjoys a national reputation. This national reputation has been demonstrated by his numerous publications as well as many presentations. Dr. Kindelberger has carried a full service load in addition to his teaching to the residents.
  • The department had a Visiting Scholar from the University of Dammam, Saudi Arabia:
    • Dr. Areej Al Nemer, an anatomic pathologist from University of Dammam was in our department from July 22nd until August 14th.  She was involved in several research projects in the Henderson Lab including a study on kidney injury caused by light chain paraproteins, and a collaborative study with the Rahimi Lab investigating IGPR2 expression in human kidney neoplasia.   Dr. Al Nemer also learned about the work of our anatomic pathology diagnostic service, and participated in some of the routine activities of the service.
  • Dr. Deborah Stearns-Kurosawa has been re-appointed IBC Chair by the Associate Vice President for Research Compliance, bravo!
  • Mostafa Belghasem, PhD, Henderson Lab, successfully defended his thesis “Pathological and Molecular Profiling in Hypertension-Induced Glomerular Injury” on Thursday, July 30th
  • From Dr. Nader Rahimi’s Lab:
    • We welcome Dr. Mehrdad Lavaei and Xueqing Zou to Department of Pathology and Laboratory of Medicine, both recently joined Dr. Rahimi’s laboratory.
    • Dr. Lavaei is pathology resident in VU University Medical Center Amsterdam, Nederland and his research is supported by the Dutch government.
    • Xueqing Zou is a PhD student at the Shandong University, China. He will be doing his thesis research work with Dr. Rahimi. Xueqing Zou research is supported with a scholarship from China.
    • We also welcome Walter Wong and Brad Pearson from BU’s MAMS program, who recently joined Dr. Rahimi’s laboratory.
  •  Barb Nikolajczyk, PhD has received a new grant; “Roles for B cells in the development of periodontal complications of type 2 diabetes” has been selected for funding. Source of funding: BU Clinical and Translational Science Institute; Funds awarded:$20,000; Budget period: August 31, 2015 – March 31, 2016
  • Debbie Stearns-Kurosawa, PhD is an invited to be a speaker at a symposium on the “Molecular Mechanisms of Vascular Disease” at the Mount Desert Biological Laboratory in Bar Harbor, Maine on October 11-15.   The symposium is organized by Dr. Hermann Haller, Professor of Medicine at the Hannover Medical School in Germany and includes speakers from the US, Israel, Europe, and Canada. Dr. Stearns-Kurosawa will speak on complement and the hemolytic uremic syndrome.
  • From the Kurosawa Lab: Two abstracts were accepted for the 9th Triennial International Symposium on Shiga Toxin (Verocytotoxin) producing Escherichia coli (VTEC) meeting on September 13-16 in Boston:
    • 1)  DJ Stearns-Kurosawa*, Arthur Fernandezǂ, Denis Garceauǂ, Shinichiro Kurosawa*.  “Passive Immunity Strategy For Shiga Toxin-HUS in Non-human Primates”.  *Department of Pathology and Laboratory Medicine, Boston University School of Medicine ǂ Thallion Pharmaceuticals, a subsidiary of Bellus Health Inc., 275, boulevard Armand-Frappier Laval (Québec)  H7V 4A7  CANADA
    • 2) DJ Stearns-Kurosawa, Caitlin S.L. Parello, Shinichiro Kurosawa.  “Retrograde Product Development for Treatment of Shiga toxin-HUS”.Department of Pathology and Laboratory Medicine, Boston University School of Medicine


Welcome to our New Graduate Students: 


Ahmad Al Moujahed, PhD Candidate  Ahmad
Greg Hall, PhD Candidate GregHallPic3
Keith Keller, Masters KeithKeller.FullSizeRender
Maya Kim, Masters maya kim3
Denis Kyabaggu, Masters Denis S  Kyabaggu
Carolina Lyon de Ana, Masters CarolinaLyondeAna..IMG_9601
Morgan Thompson, Masters Morgan Thompson
Max Vaickus, Masters 




Congratulations to Dr. Mostafa Belghasem!

September 3rd, 2015 in Student Spotlight


Mostafa Belghasem, PhD   Mostafa_RC_2014

successfully defended his thesis:

“Pathological and Molecular Profiling in  Hypertension-Induced Glomerular Injury”

 on Thursday, July 30th, 2015!

Departmental Seminar – Friday September 25

September 1st, 2015 in Spotlight

September 25th – Friday @ 2:00

Effects of Exercise, Aging and Alzheimer’s-like Mutations on Brain and Behavior

Christina Tognoni, PhD

Postdoctoral Fellow, Blusztajn Lab, Department of Pathology
Boston University School of Medicine

Refreshments at 1:45 p.m.


670 Albany Street – Lobby Level #107/108

Program Director, Barbara Slack, PhD
Program Coordinator: Debra Kiley, 414-7914

Target Audience: Faculty, Students, Residents, Greater Boston Scientific Community (advertised in MIT’s Bulletin).

At the conclusion of this activity participants will be able to: 1) report that the effects of exercise, aging, and Alzheimer’s-like mutations on cognitive abilities in mice and rats is pertinent and translatable to human patients as well as healthy individuals; 2) repeat that since the remarkable discovery of adult neuro genesis in the mammalian hippocampus, considerable effort has been devoted to unraveling the functional significance of these neurons and 3) recognize that continual turnover of neurons in the DG could contribute to the development of event unique memory traces that act or reduce interference between highly similar inputs

July 2015

August 5th, 2015 in Uncategorized

Pathology & Laboratory Medicine News Items – July 2015

  • Announcements:
    • A manuscript describing the study from Panchenko Lab was accepted for publication by Cell Cycle without any revision or resubmission. The authors discovered an unexpected role of the component of the histone acetyl trasferase complex, JADE1, in cytokinesis – which is the least described but the most crucial phase of the epithelial cell cycle progression. The study defined JADE1 protein as novel factor of tissue regeneration and a potential player in cancer pathogenesis. By the choice of the Editor-in-Chief this study will be featured in the “News & Views” of the Journal; “The novel function of JADE1 in cytokinesis of epithelial cells” by N.S. Siriwardana, R.D. Meyer, and M.V. Panchenko
    • David Sherr and his team just had a R01 score in the 1 percentile. The is the grant, with George Murphy co-PI, which is focused on manipulating AHR activity in differentiating iPSC and resulting in production of unlimited numbers of human red blood cells
    • After a long and distinguished career, Tom Christensen has retired! Here are some photos of the luncheon held in his honor:
    • Cake.cwvDm9asA_Lw9YsGTQNy8vW7ZxwCAVZZH6V
    • Family Looking On. cwvDm9asA_Lw9YsGTQNy8vW7Zxw
      Young Visitors.cwvDm9asA_Lw9YsGTQNy8vW7ZxwCA5WHC2I
    • Nancy S. Miller, MD presented the Special Session lecture, “Laboratory considerations in an era of improved microbial identification”, at the 4th International Conference and Exhibition on Pathology, July 13-15, 2015 in New Orleans, Louisiana
    • Dr. Anita Deshpande successfully passed both the Anatomic Pathology and Clinical Pathology portions of the board, BRAVO!
  • Publications ACCEPTED:
    • S. Siriwardana, R.D. Meyer, and M.V. Panchenko. “The novel function of JADE1 in cytokinesis of epithelial cells” Cell Cycle 
    • Brooks CR, Yeung MY, Chen H, Henderson JM, Ichimura T, Bonventre JV.  KIM-1/TIM-1-mediated phagocytosis links ATG5/ULK1 dependent clearance of apoptotic cells to antigen presentation.  EMBO J.  ACCEPTED FOR PUBLICATION
    • Ip, B, Cilfone, N, Belkina, AC, DeFuria, J, Jagannathan-Bogdan, M, Zhu, M, Kuchibhatla, R, McDonnell, ME, Xiao, Q, Kepler, TB, Apovian, CM, Lauffenburger, DA, and Nikolajczyk, BS. 2015. Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFa production. Obesity. (In Press)
  • Publications PUBLISHED:




July 8 2015 Faculty meeting information

July 8th, 2015 in Faculty Highlights


Faculty Meeting Agenda, Wednesday, July 8 2015, Pathology & Laboratory Medicine

12:00PM– 1:00PM Location 107/108, 670 Albany (first floor)


Noon – 12:10 (10 minutes) Changes resulting from surveys/town hall meetings – Daniel Remick

The faculty participated in two extensive surveys, several individual meetings and a town hall meeting to discuss multiple issues. Most of our meeting today will focus the future and recent initiatives, with presentations by the faculty leading these efforts. Since we are talking about moving forward, it is appropriate to briefly review the accomplishments and changes that have been made:

  • Finances: The monthly financial statements are being forwarded to all faculty. Twice per year there will be a summary overview of the Department’s financial status.
  • Promotions: The issue about promotions has been discussed during the annual evaluations, and the information from the medical school’s promotions committee has been forwarded. If there are additional questions please arrange a time to meet with me individually.
  • Compensation: The Department voted on a compensation plan, and effective July 1, 2015, virtually all faculty will be in compliance. More specifically, the salary and bonus will be result in the faculty being paid at the median compensation within seven years of initial appointment or promotion.
  • Bonus: The Mallory practice plan has completed the year in a positive financial status. Bonuses will be paid in September after the financial statements have been audited. Unfortunately, there are no funds available to provide a bonus this year to the non-FPF faculty.
  • Department Governance: Each committee specifically includes at least one Assistant Professor.
  • Additional faculty member: Our most recent recruit has decided to stay in her current position, and the other top two candidates accepted jobs back in February. As part of the strategic planning process we will review the Department’s needs and plan accordingly.
  • Communication: Several steps have been taken to improve communications
    • Reiteration of the University’s expectations for promotion
    • Forwarding financial information about the Department and the Hospital on a monthly basis
    • Bi-annual aggregated financial information
    • Additional one-on-one meetings for individualized feedback
    • Clear compensation policy tied to the academic mission of the Department
    • We should determine the format to provide feedback from students and residents?


12:10 – 12:35 (25 minutes) Education initiatives

  • PA 810 The Business of Science – Daniel Remick for Deborah Stearns-Kurosawa
  • PA 910 Human Biospecimens for Research – Ivanna Delalle
  • Master’s of Arts in Pathology – Chris Andry
  • Offsite Immunology course – Jacqueline Sharon
  • University of Damman – David Kindelberger, Joel Henderson, Nancy Miller
  • Residency education – Joel Henderson


12:35 – 12:40 Status of outreach efforts – Daniel Remick

Lemuel Shattuck Hospital – Huihong Xu

Weymouth endoscopy – Michael O’Brien

Brigham and Women’s – Ivana Delalle

Cyprus – to be determined


12:40 – 12:45 (5 minutes) Molecular testing revenue – Gail Whitney

With the departure of the Center for Human Genetics we made a decision to expand our molecular testing, rather than send out the specimens. From July 2014 – June 2015, there was a net loss of approximately $53,000.00. This loss was due to the pre-purchase of supplies and a delay in bringing a test on board. For the next year we anticipate that there will be a positive balance of $73,000.00. We are aggressively expanding our molecular testing to improve patient care by offering better service at the same price.


12:45 – 1:00 (15 minutes) Strategic planning – Daniel Remick



June 2015

July 2nd, 2015 in Uncategorized


Pathology & Laboratory Medicine News Items – June 2015


  • BMC “Be Exceptional” Awards 2015, which recognize outstanding BMC staff who demonstrate exceptional performance and dedication to fulfilling BMC’s mission and four QUEST goals: Quality, Efficiency, Satisfaction, and Total Revenue. “Chosen by a committee made up of leaders from around the hospital, they were selected for their exceptional performance, initiative and teamwork, and for embodying our RESPECT behavioral attributes. These staffers reflect BMC on its best day, every day. Congratulations to the following individuals and teams!” Two members of the Department of Pathology and Laboratory Medicine are among this year’s recipients which were awarded on June 17th in Hiebert Lounge.:
    • Sherri Dagger, one of our Pathology Histotechnologist, for her exceptional performance and dedication to fulfilling BMC’s mission and QUEST goals
    • Neil O’Neil, Laboratory Administration Operations, “this appropriately recognizes his outstanding service to BMC”
  • Shinichiro Kurosawa has accepted an invitation to serve as a member of the Host Interactions with Bacterial Pathogens Study Section at NIH at the Center for Scientific Review, for the term beginning July 01, 2015 and ending June 30, 2019
  • Daniel Remick was in Brazil last month for the 12th Annual Forum on Sepsis at the Latin-American Institute for Sepsis in Sao Paulo, Brazil:
    • Remick gave the Keynote Address at the Forum; Pathophysiologic Mechanisms in Septic Shock
    • Remick also presented at the Thematic Session – Therapeutic Interventions; Do Inhibitory Immunoglobulins Decrease Pathogen Killing and Increase Sepsis Mortality
    • He spoke again at the Thematic Session, Special Situations in Sepsis; Brain Injury and Pneumonia Prevention
  • Nader Rahimi, PhD was awarded a R21 grant from NIH/NCI entitled “IGPR-1 in colon cancer chemotherapy”. The overall of goal of this research is to study the role of IGPR-1 in colon cancer and chemo treatment. IGPR-1 is a novel protein identified in the Rahimi laboratory. IGPR-1 represents a new class of cell surface receptors involved in cell-cell recognition and mediates tumor angiogenesis, a process by which new blood vessels are recruited to growing tumor.
  • Ivana Delalle just presented an abstract at the International Conference on “The long and the short of non-coding RNAs” in Greece, June 14-19, 2015.
  • Delalle also presented “Exosomal microRNAs as biomarkers for bipolar disorder and schizophrenia” Jason Choi1, Andre Fischer 2,3, Farahnaz Sananbenesi3, and Ivana Delalle1. 1Boston University School of Medicine, Boston, MA, USA, 2Goettingen University, Goettingen, Germany, 3German Center for Degenerative Diseases (DZNE), Goettingen, Germany.  



  • New Residents:
    • Entering PGY 1s

      • Israa Laklouk, MD   Laklouk
        • Relocating from San Francisco, CA
        • Graduated from University of Tripoli in 2008
      • Mahmoud Soliman, MD  Soliman
        • Relocating from Grand Forks, ND
        • Graduated from University of Cairo in 2004

    • Transferring PGY 2s
      • Lei Li, MD  Li
        • Transferring from residency at Saint Barnabas Medical Center
        • Graduated from Xuzhou Medical College – China in 2000
      • Ram Al-Sabti, MD   Ram Al-Sabti2

        • Transferring from residency at Case Western
        • Graduated from University of Baghdad in 2009
  • Kurosawa Lab:
    • Annalyn Brown is a STaRS summer student (Summer Training as Research Scholar) in our lab and her project is about how inflammation alters susceptibility of cells to bacterial toxins.  Specifically she’ll investigate whether activation of TLR4 increases Gb3 receptor expression for Shiga toxins on endothelial cells.  Annalyn is an undergraduate student at the University of the Virgin Islands and we’re pleased to have her in our lab this summer.
    • Evan Catudal is a Master’s student in the Pathology program with experience as a medical technologist.  His thesis project is a collaborative effort between the Kurosawa and Remick labs to identify contributions of coagulation pathways to enhanced survival of mice after mild traumatic brain injury and pneumoniahasis
    • Greg Hall is a licensed veterinarian in the PhD program with interests in animal model development and development of disease pathology.  He will be working in the Kurosawa Lab on animal models of thrombotic microangiopathy for his thesis project.  joined the Kurosawa Lab coming after his first year in the PIBS Program
  • Remick Lab:
    • Gina Ellsworth, a science/biology teacher at Haverhill High School is a summer intern with the American Association of Immunologists, where she is learning laboratory techniques in the Remick Lab to create a hands -on activity and curriculum of immunology.  This activity will be demonstrated at the National Association of Biology Teachers conference in November and the curriculum will be posted to the AAI website by Spring 2016. Gina is working with postdoc Evan Chiswick, PhD.
    • Alejandro Sanoja is a rising senior from the University of Florida. He is a member of the Summer Training as Research Scholars (STaRS) program at BU. Alejandro’s STaRS internship in the Remick Lab will be with Terry Hsieh, MD/PhD candidate and focuses on investigating immune priming in a mouse model
  • Summer Training as Research Scholars Program.
    • STaRS is designed to promote access to graduate education for talented undergraduates from minority groups traditionally underrepresented in the biomedical sciences:  African-American, Hispanic,  Native American/Native Alaskan, and Pacific Islander/Native Hawaiian.  STaRS is sponsored by the Division of Graduate Medical Sciences, a recognized leader in graduate education and biomedical research.
    • STaRS is a dynamic and focused program that is designed specifically for the enhancement of skills required for successful entrance and completion of a graduate program or an MD/PhD program in the biomedical sciences.
    • STaRS offers motivated and academically talented students a valuable opportunity to confirm a strong interest in doctoral studies particularly in the areas of heart, lung and blood research.


  • Castle Graduation Dinner Celebration 2015:


IMG_0045.All Residents



















Publications ACCEPTED:

  • Emad Arafa, Philip Bondzie, Kobra Rezazadeh, Rosana D Meyer, Edward Hartsough, Joel Henderson, John H. Schwartz, Vipul Chitalia, Nader Rahimi. TMIGD1 is a novel adhesion molecule that protects epithelial cells from oxidative cell injury. American Journal of Pathology, 2015 Emad Arafa & Philip Bondzie are co-primary authors